The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 89.60
Bid: 89.10
Ask: 89.70
Change: 1.70 (1.93%)
Spread: 0.60 (0.673%)
Open: 86.50
High: 90.10
Low: 86.50
Prev. Close: 87.90
CHRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Supplementary Prospectus

18 Feb 2022 14:21

RNS Number : 1762C
Chrysalis Investments Limited
18 February 2022
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.

 

18 February 2022

 

 

Chrysalis Investments Limited (the "Company")

 

Publication of a supplementary Prospectus

 

The Company has today published a supplementary prospectus approved by the Financial Conduct Authority (the "Supplementary Prospectus"). The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules following the publication of the annual audited financial statements for the period ended 30 September 2021.

 

The Supplementary Prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 10 March 2021 (the "Prospectus") in respect of a placing programme to issue up to 600 million ordinary and/or C Shares and launch of an Open Offer, Initial Placing, Intermediaries Offer and Offer for Subscription of new Ordinary Shares.

 

A copy of the Supplementary Prospectus will shortly be available for inspection at the National Storage Mechanism which is located at https://data.fca.org.uk/#/nsm/mationalstoragemechanism.

 

The Supplementary Prospectus is also available in electronic form on the Company's website at http://chrysalisinvestments.co.uk/.

 

Neither the National Storage Mechanism website nor the Company's website nor the content of any website accessible from hyperlinks on those websites (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

Terms used but not defined in this announcement shall have the meanings given to such terms in the Prospectus.

-ENDS-

 

For further information, please contact:

 

Jupiter Asset Management:

Magnus Spence

 

 

 

+44 (0) 20 3817 1325

 

Liberum:

Darren Vickers / Owen Matthews / Chris Clarke

 

+44 (0) 20 3100 2000

Numis Securities Limited:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

 

+44 (0) 1481 749364

 

 

Media Enquiries:

 

Montfort Communications

Charlotte McMullen

 

 

+44 (0) 20 3514 0897

Chrysalis@montfort.london

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at http://chrysalisinvestments.co.uk. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

Recipients of this announcement who are considering acquiring Ordinary Shares are reminded that any such acquisition must be made only on the basis of the information contained in the prospectus which may be different from the information contained in this announcement. A subscription for Ordinary Shares is subject to specific legal or regulatory restrictions in certain jurisdictions. Persons distributing this announcement must satisfy themselves that it is lawful to do so. The Company assumes no responsibility in the event that there is a violation by any person of such restrictions.

 

This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The New Ordinary Shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and the New Ordinary Shares may not be offered or sold, directly or indirectly, within the United States except pursuant to an exemption from the registration requirements of the US Securities Act. There will be no public offer of the New Ordinary Shares in the United States.

 

Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.

 

Each of Liberum and Numis Securities which are authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum or Numis Securities (as applicable) or advice to any other person in relation to the matters contained herein. Neither Liberum, Numis Securities nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for this announcement, its contents or otherwise in connection with it or any other information relating to the Company, whether written, oral or in a visual or electronic format.

 

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

 

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIEALAPFFNAEFA
Date   Source Headline
2nd May 20247:00 amRNSQuarterly NAV Announcement and Trading Update
22nd Apr 20247:43 amRNSUpdate on claim against Revolution Beauty GroupPLC
15th Mar 20243:05 pmRNSResult of AGM & EGM
14th Mar 202412:28 pmRNSHolding(s) in Company
13th Mar 202411:36 amRNSHolding(s) in Company
11th Mar 20243:21 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSPortfolio Update
1st Mar 20243:01 pmRNSHolding(s) in Company
29th Feb 20249:48 amRNSHolding(s) in Company
8th Feb 20242:52 pmRNSUpdate from QuotedData
31st Jan 20244:46 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSQuarterly NAV Announcement and Trading Update
29th Jan 20247:00 amRNSNotice of AGM and Notice of EGM
29th Jan 20247:00 amRNSAnnual Results
12th Dec 20231:17 pmRNSHolding(s) in Company
11th Dec 202311:25 amRNSHolding(s) in Company
5th Dec 20232:14 pmRNSPortfolio Update
4th Dec 20233:32 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSInvestment Management Arrangements Update
30th Oct 20237:00 amRNSQuarterly NAV Announcement and Trading Update
13th Oct 20237:30 amRNSShareholder Update and Consultation
25th Sep 202310:09 amRNSHolding(s) in Company
13th Sep 20233:44 pmRNSHolding(s) in Company
11th Sep 20235:03 pmRNSHolding(s) in Company
7th Sep 20234:07 pmRNSHolding(s) in Company
21st Aug 202312:17 pmRNSHoldings in Company
31st Jul 20237:00 amRNSQuarterly NAV Announcement and Trading Update
27th Jul 20234:37 pmRNSUpdate from QuotedData
27th Jun 20237:00 amRNSInterim Results
13th Jun 202310:20 amRNSHolding(s) in Company
9th Jun 202312:06 pmRNSHolding(s) in Company
1st Jun 20233:10 pmRNSPortfolio Update
25th May 20239:14 amRNSPortfolio Update
15th May 20237:00 amRNSPortfolio Update
4th May 202310:00 amRNSQuarterly NAV Announcement and Trading Update
19th Apr 20233:16 pmRNSChange of Registered Office
21st Mar 20235:14 pmRNSResult of AGM
1st Mar 20233:15 pmRNSNotice of AGM
10th Feb 202310:34 amRNSHolding(s) in Company
7th Feb 20234:26 pmRNSPortfolio Update
1st Feb 20237:00 amRNSQuarterly NAV Announcement and Trading Update
31st Jan 20237:00 amRNSAnnual Results
6th Jan 20233:20 pmRNSHolding(s) in Company
15th Dec 20221:17 pmRNSHolding(s) in Company
30th Nov 20227:30 amRNSCapital Markets Event
30th Nov 20227:00 amRNSUpdate on Performance Fee Arrangements
25th Nov 202212:18 pmRNSPortfolio Update
21st Nov 20228:30 amRNSQuarterly NAV Announcement and Trading Update
21st Nov 20227:00 amRNSQuarterly NAV Announcement and Trading Update
21st Sep 20222:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.